Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DAUNOXOME
- Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia
- Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years
- International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
- Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
- DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML
- Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
- Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia
- Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents
- Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy
- Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer
- Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
- A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.
Clinical trials list
click for details